33.27
price down icon0.15%   -0.08
 
loading
Schlusskurs vom Vortag:
$33.35
Offen:
$33.4
24-Stunden-Volumen:
2.09M
Relative Volume:
0.38
Marktkapitalisierung:
$68.04B
Einnahmen:
$39.71B
Nettoeinkommen (Verlust:
$3.17B
KGV:
9.665
EPS:
3.4423
Netto-Cashflow:
$6.05B
1W Leistung:
-3.17%
1M Leistung:
-12.74%
6M Leistung:
-25.10%
1J Leistung:
-5.88%
1-Tages-Spanne:
Value
$33.24
$33.41
1-Wochen-Bereich:
Value
$32.83
$33.79
52-Wochen-Spanne:
Value
$32.83
$45.92

Gsk Plc Adr Stock (GSK) Company Profile

Name
Firmenname
Gsk Plc Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
70,200
Name
Twitter
@GSK
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
GSK's Discussions on Twitter

Vergleichen Sie GSK mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
GSK 33.27 68.04B 39.71B 3.17B 6.05B 3.4423
LLY 745.15 693.54B 40.86B 8.37B -2.28B 5.4193
NVO 102.20 465.74B 39.36B 13.79B 9.83B 2.4077
JNJ 154.77 353.35B 87.70B 14.68B 19.03B 13.47
ABBV 170.68 294.70B 55.53B 5.12B 15.62B 3.65
MRK 98.52 248.54B 63.17B 12.15B 14.84B 1.80

Gsk Plc Adr Stock (GSK) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-08 Herabstufung UBS Buy → Neutral
2024-05-30 Eingeleitet Goldman Neutral
2024-03-04 Hochstufung Guggenheim Neutral → Buy
2024-02-13 Hochstufung Citigroup Neutral → Buy
2024-01-23 Eingeleitet Morgan Stanley Equal-Weight
2024-01-16 Fortgesetzt UBS Buy
2024-01-03 Hochstufung Jefferies Hold → Buy
2023-07-14 Eingeleitet HSBC Securities Reduce
2023-03-17 Hochstufung Deutsche Bank Hold → Buy
2023-02-27 Fortgesetzt Goldman Buy
2023-01-03 Herabstufung JP Morgan Neutral → Underweight
2022-12-05 Herabstufung BofA Securities Neutral → Underperform
2022-11-11 Herabstufung UBS Neutral → Sell
2022-09-15 Hochstufung Credit Suisse Underperform → Neutral
2022-09-08 Herabstufung Jefferies Buy → Hold
2022-08-05 Fortgesetzt Morgan Stanley Equal-Weight
2022-07-21 Fortgesetzt Citigroup Neutral
2022-02-11 Herabstufung DZ Bank Buy → Hold
2021-11-05 Hochstufung Barclays Underweight → Equal Weight
2021-06-24 Hochstufung Deutsche Bank Sell → Hold
2021-03-23 Herabstufung SVB Leerink Outperform → Mkt Perform
2021-02-04 Herabstufung Deutsche Bank Hold → Sell
2021-01-20 Herabstufung Credit Suisse Neutral → Underperform
2021-01-15 Eingeleitet Deutsche Bank Hold
2020-11-02 Hochstufung Liberum Hold → Buy
2020-09-29 Eingeleitet Berenberg Buy
2020-02-12 Herabstufung Shore Capital Hold → Sell
2020-01-16 Herabstufung Barclays Equal Weight → Underweight
2019-12-02 Eingeleitet SVB Leerink Outperform
2019-11-21 Hochstufung UBS Neutral → Buy
2019-10-11 Hochstufung Cantor Fitzgerald Hold → Buy
2019-09-03 Fortgesetzt Citigroup Neutral
2019-09-03 Hochstufung Societe Generale Sell → Buy
2019-08-13 Fortgesetzt JP Morgan Neutral
2019-06-17 Fortgesetzt Morgan Stanley Underweight
2019-03-08 Herabstufung Shore Capital Buy → Hold
2019-02-22 Herabstufung UBS Buy → Neutral
2019-01-14 Herabstufung Exane BNP Paribas Outperform → Neutral
2018-12-11 Fortgesetzt Jefferies Buy
2018-10-09 Eingeleitet Guggenheim Neutral
2018-08-30 Herabstufung Liberum Buy → Hold
2018-04-04 Hochstufung Exane BNP Paribas Neutral → Outperform
2018-03-22 Hochstufung Morgan Stanley Underweight → Equal-Weight
2018-02-09 Hochstufung Kepler Reduce → Hold
Alle ansehen

Gsk Plc Adr Aktie (GSK) Neueste Nachrichten

pulisher
Nov 19, 2024

GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients - Benzinga

Nov 19, 2024
pulisher
Nov 18, 2024

5 Stocks to Buy While They’re Still Cheap After Earnings - Morningstar

Nov 18, 2024
pulisher
Nov 13, 2024

Diabetes Care Nutrition Market Report 2024 with Forecasts to 2029 - GlobeNewswire Inc.

Nov 13, 2024
pulisher
Nov 12, 2024

The 10 Best Companies to Invest in Now - Morningstar

Nov 12, 2024
pulisher
Nov 04, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 04, 2024
pulisher
Nov 04, 2024

The Best Defensive Stocks to Buy - Morningstar

Nov 04, 2024
pulisher
Nov 01, 2024

GSK Plc ADR (NYSE: GSK) Has Outstanding Potential - Stocks Register

Nov 01, 2024
pulisher
Oct 30, 2024

GSK (GSK) Q3 Earnings Surpass Estimates - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

What Do Analysts Think About ICICI Bank Ltd. ADR’s (NYSE:IBN) Future? - Stocks Register

Oct 29, 2024
pulisher
Oct 25, 2024

GSK Plc ADR (GSK): An Important Analyst Insights - Stocks Register

Oct 25, 2024
pulisher
Oct 21, 2024

5 Stocks to Buy if You’re Concerned About US Market Valuations - Morningstar

Oct 21, 2024
pulisher
Oct 18, 2024

21 Best Healthcare Companies to Invest In - Morningstar

Oct 18, 2024
pulisher
Oct 16, 2024

Current share price is - GSK

Oct 16, 2024
pulisher
Oct 15, 2024

D-Wave Quantum Inc (QBTS) rating initates by B. Riley Securities - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

GSK's Studies On Depemokimab For Nasal Polyps Meet Primary Goals - Barchart

Oct 15, 2024
pulisher
Oct 15, 2024

Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.

Oct 15, 2024
pulisher
Oct 15, 2024

GSK Plc ADR [GSK] is 5.59% higher this YTD. Is it still time to buy? - The DBT News

Oct 15, 2024
pulisher
Oct 14, 2024

What You Didn’t Know About General Motors Company (NYSE: GM) This Week - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

GSK’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Before You Invest, Make Sure You Check This ADT Inc (NYSE: ADT) Analysis - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

What Are You Thinking About Investing In Medical Properties Trust Inc (NYSE: MPW) Stock? - Stocks Register

Oct 14, 2024
pulisher
Oct 10, 2024

Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday - sharewise

Oct 10, 2024
pulisher
Oct 10, 2024

Introducing Our Rant Against GSK Plc ADR - US Post News

Oct 10, 2024
pulisher
Oct 10, 2024

GSK Posts New Data From Phase III Study on RSV Vaccine Arexvy - Zacks Investment Research

Oct 10, 2024
pulisher
Oct 09, 2024

Balance Sheet Insights: GSK Plc ADR (GSK)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

Pilgrim’s Pride Corp. (PPC) receives an Equal-weight rating from Stephens - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Berenberg upgrades Carnival plc ADR (CUK) stock to a Hold - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

JP Morgan analysts downgrades an Underweight rating for Organon & Co. (OGN) - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

GSK Plc ADR (GSK) gets rating Downgrade from UBS - Knox Daily

Oct 09, 2024
pulisher
Oct 08, 2024

GSK Plc ADR (GSK) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Oct 08, 2024
pulisher
Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe - Traders Magazine

Oct 07, 2024
pulisher
Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe, Providing Exposure to Individual International Companies with an Embedded Currency Hedge - PR Newswire

Oct 07, 2024
pulisher
Oct 04, 2024

Tenet Healthcare Corp. [THC] stock for 1,879,734 USD was sold by Ramsey R. Scott - Knox Daily

Oct 04, 2024
pulisher
Oct 03, 2024

Ratio Analysis: Unpacking GSK Plc ADR (GSK)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 03, 2024
pulisher
Oct 02, 2024

GSK Plc ADR [GSK] Insider Activity: An Update for Investors - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

GSK Plc ADR (GSK) Stock: Navigating a Year of Stock Volatility - The InvestChronicle

Oct 02, 2024
pulisher
Oct 02, 2024

Cantor Fitzgerald’s latest rating for AMGN stock - Knox Daily

Oct 02, 2024
pulisher
Sep 27, 2024

Nutanix Inc [NTNX] Chief Financial Officer makes an insider sale of 24,316 shares worth 1,430,939. - Knox Daily

Sep 27, 2024
pulisher
Sep 26, 2024

GSK’s Stock Market Adventure: 9.44% YTD Growth Amidst Volatility - The InvestChronicle

Sep 26, 2024
pulisher
Sep 26, 2024

GSK Shares Experience Decline in Value - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

The Best Healthcare Stocks to Buy - Morningstar

Sep 26, 2024

Finanzdaten der Gsk Plc Adr-Aktie (GSK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general BMY
$57.53
price down icon 0.70%
drug_manufacturers_general SNY
$47.64
price down icon 0.22%
drug_manufacturers_general PFE
$24.93
price up icon 0.01%
$286.05
price down icon 0.09%
drug_manufacturers_general NVS
$103.35
price down icon 0.20%
drug_manufacturers_general MRK
$97.70
price up icon 1.40%
Kapitalisierung:     |  Volumen (24h):